<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Abstract Background Characterization of novel fusion genes in acute leukemia is important for gaining information about leukemia genesis. We describe the characterization of a new ETV6 fusion gene in acute myeloid leukemia (AML) FAB M0 as a result of an uncommon translocation involving chromosomes 12 and 15. Methods The ETV6 locus at 12p13 was shown to be translocated and to constitute the 5' end of the fusion product by ETV6 break apart fluorescence in situ hybridisation (FISH). To identify a fusion partner 3' rapid amplification of cDNA-ends with polymerase chain reaction (RACE PCR) was performed followed by cloning and sequencing. Results The NTRK3 gene on chromosome 15 was found to constitute the 3' end of the fusion gene and the underlying ETV6-NTRK3 rearrangement was verified by reverse transcriptase PCR. No RNA of the reciprocal NTRK3-ETV6 fusion gene could be detected. Conclusion We have characterized a novel ETV6-NTRK3 fusion transcript which has not been previously described in AML FAB M0 by FISH and RACE PCR. ETV6-NTRK3 rearrangements have been described in secretory breast carcinoma and congenital fibrosarcoma.
Chromosome Aberrations, Gene Rearrangement, Male, Chromosomes, Human, Pair 15, Histology, Chromosomes, Human, Pair 12, Oncogene Proteins, Fusion, Research, DNA Mutational Analysis, DNA, Neoplasm, Middle Aged, Pathology and Forensic Medicine, Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols, Pathology, RB1-214, Humans, Cloning, Molecular, In Situ Hybridization, Fluorescence
Chromosome Aberrations, Gene Rearrangement, Male, Chromosomes, Human, Pair 15, Histology, Chromosomes, Human, Pair 12, Oncogene Proteins, Fusion, Research, DNA Mutational Analysis, DNA, Neoplasm, Middle Aged, Pathology and Forensic Medicine, Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols, Pathology, RB1-214, Humans, Cloning, Molecular, In Situ Hybridization, Fluorescence
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 91 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |